D Elstein - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D Elstein

Showing results (81-90 of 84) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 84 results.

Blood Cells, Molecules & Diseases|December 4, 2012

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher diseaseL van Dussen, A Zimran, E M Akkerman, et al.

Journal of Inherited Metabolic Disease|October 27, 2004

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.

Journal of Inherited Metabolic Disease|June 19, 2001

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapyF M Platt, M Jeyakumar, U Andersson, et al.

Journal of Inherited Metabolic Disease|November 8, 2003

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statementT M Cox, J M F G Aerts, G Andria, et al.

Pageof 9

Search research articles

Showing results (81-90 of 84) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 84 results.

Blood Cells, Molecules & Diseases|December 4, 2012

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher diseaseL van Dussen, A Zimran, E M Akkerman, et al.

Journal of Inherited Metabolic Disease|October 27, 2004

Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher diseaseD Elstein, C Hollak, J M F G Aerts, et al.

Journal of Inherited Metabolic Disease|June 19, 2001

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapyF M Platt, M Jeyakumar, U Andersson, et al.

Journal of Inherited Metabolic Disease|November 8, 2003

The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statementT M Cox, J M F G Aerts, G Andria, et al.

Pageof 9